Article Listing - Novartis buys back exclusive US/Canada rights from Vanda Pharmaceuticals for Fanapt in deal worth up to $465 million

PROFITS UP AT ITALIAN SORIN BIOMEDICA IN 1991

6 April 1992

Sorin Biomedica made net profits in 1991 of 12.3 billion lire ($9.9 billion), up from 11 billion lire in the...

GENENTECH REBUFFS ISIS-3 AND AWAITS GUSTO

6 April 1992

With the formal publication in The Lancet last week of the results of the ISIS-3 thrombolytic product trial, the major...

CORTECS' NSAID TARGETING STRATEGY

6 April 1992

Researchers at UK-based Cortecs Limited have published results of studies in volunteers concerning its technology aimed at improving the bioavailability...

AUSTRALIAN DRUG PROMOTION STUDY

6 April 1992

In Australia, a parliamentary report from the House of Representatives concludes that there is no evidence that hospitality provided...

MG FRANCE ATTACKS GOVT COST-CUTTING

6 April 1992

The association of doctors in France, MG France, has attacked the agreement on health care expenditures which has been...

MILES STAFF CUTS

6 April 1992

Miles Inc of the USA is to reduce its workforce at its Diagnostics Business Group by 600, around 9%. The...

MGI PHARMA'S SALAGEN

6 April 1992

MGI Pharma has gained orphan drug status from the US Food and Drug Administration for Salagen (pilocarpine), to treat dry...

PFIZER'S DIFLUCAN

6 April 1992

Prophylactic administration of Pfizer's Diflucan (fluconazole) to recipients of autologous bone marrow transplants reduces the incidence of both systemic and...

Mexican Health Ministry Merges

6 April 1992

In a major shake-up within the Mexican administration, the government is proposing to merge the Ministry of Health with the...

HERBAL MEDICINES IN ASIA 1992-96

6 April 1992

The international management consulting company McAlpine Thorpe and Warrier Ltd, which specializes in the field of herbal medicines, has announced...

Showing 94451-94460 of 95353 articles